The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice
Abstract The tumor suppressor and chromatin modifier cAMP response element-binding protein binding protein (CREBBP) and v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN), a member of the MYC oncogene family, are critically involved in brain development. Both genes are...
Main Authors: | Melanie Schoof, Gefion Dorothea Epplen, Carolin Walter, Annika Ballast, Dörthe Holdhof, Carolin Göbel, Sina Neyazi, Julian Varghese, Thomas Karl Albert, Kornelius Kerl, Ulrich Schüller |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-07-01
|
Series: | Oncogenesis |
Online Access: | https://doi.org/10.1038/s41389-023-00481-3 |
Similar Items
-
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
by: Melanie Schoof, et al.
Published: (2023-11-01) -
MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice
by: Carolin Göbel, et al.
Published: (2023-11-01) -
Oncogene/Tumor Suppressor Molecular Pathways
by: Dan Cushman, et al.
Published: (2010-04-01) -
CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors
by: Valeria Barresi, et al.
Published: (2024-01-01) -
SIRT3: Oncogene and Tumor Suppressor in Cancer
by: Margalida Torrens-Mas, et al.
Published: (2017-07-01)